Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1400 of 3284 entries
View as:

Cardiovascular Risk in General Practice in France: Cardiovascular Risk Week

Phase: N/A Priority: Normal
NCT ID: NCT01308372 Org: User:
Start: 10/31/11 End: 10/31/11 Due: 10/31/12

Bioequivalence Study of Fixed-dose Combinations and Coadministered Individual Tablets of Saxagliptin/Metformin-Brazil

Phase: N/A Priority: Normal
NCT ID: NCT01365091 Org: User:
Start: 06/30/11 End: 11/30/11 Due: 11/30/12

US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI)

Phase: N/A Priority: Normal
NCT ID: NCT04125290 Org: User:
Start: 12/09/19 End: 06/21/21 Due: 06/21/22

AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00610714 Org: User:
Start: 04/30/08 End: 01/31/12 Due: 01/31/13

Selumetinib in Chinese Paediatric With Post-operative NF1-PNs, PhaseⅡ, Double-Blinded, Placebo-Controlled Study

Phase: N/A Priority: Normal
NCT ID: NCT05825365 Org: User:
Start: 08/31/23 End: 06/30/26 Due: 06/30/27

Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01197794 Org: User:
Start: 10/31/10 End: 02/29/12 Due: 02/28/13

Multiple Dose Study of Safety and Pharmacokinetics of MEDI0618 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05714254 Org: User:
Start: 12/12/22 End: 12/12/23 Due: 12/12/24

AZD Single Ascending Dose Study In Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01028040 Org: User:
Start: 12/31/09 End: 08/31/10 Due: 08/31/11

Pharmacokinetics and Pharmacodynamics Study of Saxagliptin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00935467 Org: User:
Start: 07/31/09 End: 08/31/09 Due: 08/31/10

Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00081380 Org: User:
Start: 03/31/04 End: 09/30/06 Due: 09/30/07

Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)

Phase: N/A Priority: Normal
NCT ID: NCT03186209 Org: User:
Start: 09/07/17 End: 01/30/23 Due: 01/30/24

Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)

Phase: N/A Priority: Normal
NCT ID: NCT00807053 Org: User:
Start: 04/30/07 End: 07/31/07 Due: 07/31/08

Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria

Phase: N/A Priority: Normal
NCT ID: NCT03118739 Org: User:
Start: 05/18/17 End: 08/13/18 Due: 08/13/19

A Study to Assess the Reaction of Body for Four Different Formulations of AZD9977 (Part A) and Influence of Food and Lower Dose of a Selected Formulation (Part B) in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03804645 Org: User:
Start: 02/05/19 End: 04/16/19 Due: 04/16/20

Study to Assess the Blood Levels and Safety of Olaparib in Patients With Advanced Solid Tumours and Normal or Impaired Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT01894256 Org: User:
Start: 11/30/13 End: 02/29/16 Due: 02/28/17

Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity

Phase: N/A Priority: Normal
NCT ID: NCT00884247 Org: User:
Start: 04/30/09 End: 06/30/09 Due: 06/30/10

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Saxagliptin as Monotherapy in Pediatric Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01204775 Org: User:
Start: 06/30/11 End: 04/30/16 Due: 04/30/17

A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC

Phase: N/A Priority: Normal
NCT ID: NCT07000149 Org: User:
Start: 07/08/25 End: 07/29/32 Due: 07/29/33

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Phase: N/A Priority: Normal
NCT ID: NCT07000357 Org: User:
Start: 06/06/25 End: 10/26/29 Due: 10/26/30

Anifrolumab Malignancy and Serious Infections Study

Phase: N/A Priority: Normal
NCT ID: NCT07000110 Org: User:
Start: 05/31/25 End: 11/30/31 Due: 11/30/32

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event

Phase: N/A Priority: Normal
NCT ID: NCT07000123 Org: User:
Start: 05/30/25 End: 03/26/27 Due: 03/26/28

Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an Ileostomy

Phase: N/A Priority: Normal
NCT ID: NCT06681324 Org: User:
Start: 12/11/24 End: 06/18/27 Due: 06/18/28

Evaluation of Tolerability and Pharmacokinetics of Roflumilast, 250μg and 500μg, as add-on to Standard COPD Treatment to Treat Severe COPD

Phase: N/A Priority: Normal
NCT ID: NCT02165826 Org: User:
Start: 05/01/14 End: 09/01/15 Due: 09/01/16

GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00280865 Org: User:
Start: 04/30/02 End: 06/30/03 Due: 06/30/04

To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.

Phase: N/A Priority: Normal
NCT ID: NCT03286842 Org: User:
Start: 01/17/18 End: 10/08/21 Due: 10/08/22